tradingkey.logo

Autonomix Medical Inc

AMIX
0.598USD
-0.002-0.28%
Close 12/24, 13:00ETQuotes delayed by 15 min
3.71MMarket Cap
LossP/E TTM

Autonomix Medical Inc

0.598
-0.002-0.28%

More Details of Autonomix Medical Inc Company

Autonomix Medical, Inc. is a medical device company focused on advancing technologies to develop how diseases involving the nervous system are diagnosed and treated. The Company’s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity. It is developing its technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. Its technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Its development efforts are divided into two parts: diagnostic sensing and therapeutic radiofrequency ablation. The Company is developing Autonomix system, which is primarily catheter-based, meaning that its sensing equipment is delivered to its targeted location via a lumen within the body.

Autonomix Medical Inc Info

Ticker SymbolAMIX
Company nameAutonomix Medical Inc
IPO dateJan 29, 2024
CEOHauser (Bradley)
Number of employees8
Security typeOrdinary Share
Fiscal year-endJan 29
Address21 Waterway Ave, Suite 300
CityTHE WOODLANDS
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code77380
Phone18322777816
Websitehttps://autonomix.com/
Ticker SymbolAMIX
IPO dateJan 29, 2024
CEOHauser (Bradley)

Company Executives of Autonomix Medical Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Landy Toth
Mr. Landy Toth
Chief Technology Officer
Chief Technology Officer
101.31K
--
Mr. Robert Schwartz
Mr. Robert Schwartz
Chief Medical Officer
Chief Medical Officer
35.77K
--
Mr. Bradley (Brad) Hauser
Mr. Bradley (Brad) Hauser
President, Chief Executive Officer
President, Chief Executive Officer
11.25K
--
Mr. David Andrew Robins
Mr. David Andrew Robins
Independent Director
Independent Director
10.98K
--
Mr. Trent N. Smith
Mr. Trent N. Smith
Chief Financial Officer
Chief Financial Officer
3.75K
--
Dr. Christopher Capelli, M.D.
Dr. Christopher Capelli, M.D.
Independent Director
Independent Director
3.75K
--
Mr. Walter V. Klemp
Mr. Walter V. Klemp
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Ms. Lori H. Bisson
Ms. Lori H. Bisson
Executive Vice Chairman of the Board
Executive Vice Chairman of the Board
--
--
Mr. Jonathan P. Foster
Mr. Jonathan P. Foster
Independent Director
Independent Director
--
--
Ms. Jenene Thomas
Ms. Jenene Thomas
Investor Relations
Investor Relations
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Landy Toth
Mr. Landy Toth
Chief Technology Officer
Chief Technology Officer
101.31K
--
Mr. Robert Schwartz
Mr. Robert Schwartz
Chief Medical Officer
Chief Medical Officer
35.77K
--
Mr. Bradley (Brad) Hauser
Mr. Bradley (Brad) Hauser
President, Chief Executive Officer
President, Chief Executive Officer
11.25K
--
Mr. David Andrew Robins
Mr. David Andrew Robins
Independent Director
Independent Director
10.98K
--
Mr. Trent N. Smith
Mr. Trent N. Smith
Chief Financial Officer
Chief Financial Officer
3.75K
--
Dr. Christopher Capelli, M.D.
Dr. Christopher Capelli, M.D.
Independent Director
Independent Director
3.75K
--

Revenue Breakdown

Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Klemp (Walter V.)
2.18%
BioStar Ventures III, L.P.
1.75%
Heights Capital Management, Inc.
1.68%
Toth (Landy)
1.47%
Mariner Wealth Advisors
1.46%
Other
91.46%
Shareholders
Shareholders
Proportion
Klemp (Walter V.)
2.18%
BioStar Ventures III, L.P.
1.75%
Heights Capital Management, Inc.
1.68%
Toth (Landy)
1.47%
Mariner Wealth Advisors
1.46%
Other
91.46%
Shareholder Types
Shareholders
Proportion
Individual Investor
5.18%
Investment Advisor
3.53%
Corporation
1.75%
Hedge Fund
0.89%
Venture Capital
0.20%
Investment Advisor/Hedge Fund
0.15%
Other
88.29%

Institutional Shareholding

Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
39
329.96K
7.13%
--
2025Q3
39
329.96K
7.93%
+35.06K
2025Q2
35
294.92K
16.34%
-135.37K
2025Q1
30
430.29K
14.58%
+71.16K
2024Q4
29
489.76K
8.72%
+336.46K
2024Q3
25
18.30K
0.40%
+13.75K
2024Q2
19
4.55K
0.18%
+2.81K
2024Q1
10
1.66K
0.00%
+1.66K

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Klemp (Walter V.)
150.75K
2.43%
--
--
Sep 19, 2025
BioStar Ventures III, L.P.
120.82K
1.95%
--
--
Jun 30, 2025
Heights Capital Management, Inc.
116.09K
1.87%
-18.91K
-14.01%
Dec 31, 2024
Toth (Landy)
101.31K
1.64%
--
--
Sep 19, 2025
Mariner Wealth Advisors
100.64K
1.62%
--
--
Jun 30, 2025
Foster (Jonathan P.)
36.56K
0.59%
--
--
Sep 19, 2025
Schwartz (Robert)
35.77K
0.58%
--
--
Sep 19, 2025
Ikarian Capital LLC
20.00K
0.32%
--
--
Jun 30, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proportion0%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Split

Date
Type
Ratio
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
Date
Type
Ratio
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1

FAQs

Who are the top five shareholders of Autonomix Medical Inc?

The top five shareholders of Autonomix Medical Inc are:
Klemp (Walter V.) holds 150.75K shares, accounting for 2.43% of the total shares.
BioStar Ventures III, L.P. holds 120.82K shares, accounting for 1.95% of the total shares.
Heights Capital Management, Inc. holds 116.09K shares, accounting for 1.87% of the total shares.
Toth (Landy) holds 101.31K shares, accounting for 1.64% of the total shares.
Mariner Wealth Advisors holds 100.64K shares, accounting for 1.62% of the total shares.

What are the top three shareholder types of Autonomix Medical Inc?

The top three shareholder types of Autonomix Medical Inc are:
Klemp (Walter V.)
BioStar Ventures III, L.P.
Heights Capital Management, Inc.

How many institutions hold shares of Autonomix Medical Inc (AMIX)?

As of 2025Q4, 39 institutions hold shares of Autonomix Medical Inc, with a combined market value of approximately 329.96K, accounting for 7.13% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -0.80%.

What is the biggest source of revenue for Autonomix Medical Inc?

In --, the -- business generated the highest revenue for Autonomix Medical Inc, amounting to -- and accounting for --% of total revenue.
KeyAI